AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.2650
-0.0150 (-5.36%)
At close: Apr 9, 2026
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $4.26 million as of April 10, 2026. Its market cap has increased by 13.77% in one year.
Market Cap
4.26M
Enterprise Value
4.29M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.27
Market Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has decreased from 20.42M to 4.26M, a decrease of -79.14%. That is a compound annual growth rate of -31.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 4.26M | -67.43% |
| Dec 31, 2025 | 13.07M | 157.22% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
| Mar 2, 2022 | 20.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Synlogic | 7.31M |
| Nymox Pharmaceutical | 6.12M |
| Mosaic ImmunoEngineering | 5.03M |
| Bioxytran | 4.95M |
| Biomind Labs | 4.34M |
| GPL Holdings | 4.17M |
| Oncology Pharma | 3.87M |
| Galera Therapeutics | 3.13M |